Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (251-260 of 387) with videos related to

Pageof 39
Sort By:
Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosisAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
British Journal of Haematology|April 16, 2003
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemiaGordon W Dewald, Stephanie R Brockman, Sarah F Paternoster, et al.
British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.
American Journal of Hematology|June 22, 2012
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau, Matthew J Maurer, Zachary S Fredericksen, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Blood|May 19, 2019
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphomaXiaosheng Wu, Mary Stenson, Jithma Abeykoon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2018
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed LymphomaLeslie Padrnos, Brenda Ernst, Amylou C Dueck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology ResourceBrian K Link, Matthew J Maurer, Grzegorz S Nowakowski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2022
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic ExperienceJustin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, et al.
Pageof 39

Showing results (251-260 of 387) with videos related to

Sort By:
Pageof 39
Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosisAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
British Journal of Haematology|April 16, 2003
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemiaGordon W Dewald, Stephanie R Brockman, Sarah F Paternoster, et al.
British Journal of Haematology|August 7, 2018
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cellsAneel Paulus, Alak Manna, Sharoon Akhtar, et al.
American Journal of Hematology|June 22, 2012
Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaBridget Charbonneau, Matthew J Maurer, Zachary S Fredericksen, et al.
Cancer Genetics and Cytogenetics|January 22, 2002
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progressionRoelandt F J Schop, Syed M Jalal, Scott A Van Wier, et al.
Blood|May 19, 2019
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphomaXiaosheng Wu, Mary Stenson, Jithma Abeykoon, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2018
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed LymphomaLeslie Padrnos, Brenda Ernst, Amylou C Dueck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology ResourceBrian K Link, Matthew J Maurer, Grzegorz S Nowakowski, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2022
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic ExperienceJustin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, et al.
Pageof 39